Are you Dr. Absalon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 54 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
506 Malcolm X Blvd
Wp-522
New York, NY 10037Phone+1 212-939-2740Fax+1 212-939-2759- Is this information wrong?
Summary
- Dr. Judith Absalon, MD is an internist in New York, New York. She is currently licensed to practice medicine in New York.
Education & Training
- Harlem Hospital CenterFellowship, Infectious Disease, 2001 - 2002
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1996 - 1999
- Stony Brook University Health Sciences Center School of MedicineClass of 1996
Certifications & Licensure
- NY State Medical License 1998 - 2025
Publications & Presentations
PubMed
- 801 citationsSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.Stephen J. Thomas, Edson D. Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Fernando P. Polack, Cris...> ;The New England Journal of Medicine. 2021 Sep 15
- 255 citationsSARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.Ann R. Falsey, Robert W. Frenck, Edward E. Walsh, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Ruth Bailey, Kena A. Swanson, Xia Xu, Kenneth ...> ;The New England Journal of Medicine. 2021 Sep 15
- 5 citationsPersistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety...Lars Østergaard, Timo Vesikari, Shelly Senders, Carl-Erik Flodmark, Pavel Kosina, Han-Qing Jiang, Jason Maguire, Judith Absalon, Kathrin U. Jansen, Shannon L. Harris, ...> ;Vaccine. 2021 Jul 22
- Join now to see all
Press Mentions
- Second Community Health Worker Town Hall Addresses Vaccine Safety and EfficacyApril 17th, 2021
- Crumpler Symposia Breaks Ground, Creates Lively Discussion About What Is PossibleFebruary 2nd, 2021
- Publisher Correction: Phase I/II Study of COVID-19 RNA Vaccine BNT162b1 in AdultsJanuary 19th, 2021
- Join now to see all